Psychedelics Investing Archives

4 minute read

Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD’s Perceived Risks, Knowledge Gaps, Surveys & More

January 15, 2:38 PM

Welcome to Benzinga's weekly psychedelics headlines roundup. This is our pick of must-read news items from the second week of January 2024.

ATAI

3 minute read

Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More

By Lara Goldstein

January 12, 5:55 PM

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD

ATAI

9 minute read

30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond

By Lara Goldstein

January 10, 8:56 PM

The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substances like psilocybin and MDMA to treat mental health conditions, this sector has attracted growing attention and investment.

CYBN

3 minute read

Atai Invests $50M In Beckley Psytech For Short-Duration Psychedelics Development

By Lara Goldstein

January 4, 3:17 PM

Biopharma and resources-pooling company Atai Life Sciences (NASDAQ: ATAI) has invested a total of $50 million in Beckley Psytech Ltd., a U.K.-based clinical-stage biotech advancing short-duration psychedelics for neuropsychiatric conditions.

ATAI

4 minute read

Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More

By Lara Goldstein

December 11, 11:43 AM

John Lennon Remembered 43 Years After His Murder In New York, Psychedelic Adventures & Enduring Legacy

ATAI

4 minute read

Psyched: Cybin’s Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney’s Memoirs And More

By Lara Goldstein

October 29, 10:48 PM

Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted

ATAI

2 minute read

Cybin’s FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor

By Lara Goldstein

June 28, 2:34 PM

Psychedelics biopharma company Cybin Inc. (NYSE: CYBN) shared its financial results for the fiscal year ended this March 31 as well as recent business highlights. Numbers show: Total cash of $12.5 (CA$16.6) million by March 31, 2023.

CYBN

3 minute read

Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah’s Guest, Swiss MDMA & More

By Lara Goldstein

June 13, 10:31 AM

Science Conference In Dubai, UAE Hosts Discussion On Psychedelics Research

BETRF

3 minute read

Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More

By Lara Goldstein

May 31, 11:59 AM

Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study Australian psychedelics company MindBio Therapeutics Corp. was granted approval by both the Ethics committee and the Clinical Trials Registry to begin the world's first Phase 2a take-home LSD microdosing trial in patients with Major Depressive Disorder (MDD).

CMPS

3 minute read

EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps

By Lara Goldstein

April 19, 10:04 AM

In the current psychedelics landscape, one of the most important topics is compound legality. While it's possible that MDMA-assisted therapy will eventually be federally approved in the U.S., what should investors consider when looking at a prospective business?

AWKNF

Feed Tag: Psychedelics Investing